Additional Authorizations Across Australia are Expected to Follow
CAMBRIDGE, Mass. (August 20, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomo-trained Orthotic & Prosthetic (“O&P”) practice in Australia has received its first insurance authorization to fit a patient with a custom MyoPro device. This is the first authorization following Myomo’s entry into Australia as part of its international expansion initiative. Read more.